JP2001039959A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2001039959A5 JP2001039959A5 JP1999211798A JP21179899A JP2001039959A5 JP 2001039959 A5 JP2001039959 A5 JP 2001039959A5 JP 1999211798 A JP1999211798 A JP 1999211798A JP 21179899 A JP21179899 A JP 21179899A JP 2001039959 A5 JP2001039959 A5 JP 2001039959A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- antigen
- binding
- compound
- fragment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 description 16
- 239000000427 antigen Substances 0.000 description 14
- 102000036639 antigens Human genes 0.000 description 14
- 108091007433 antigens Proteins 0.000 description 14
- 239000012634 fragment Substances 0.000 description 11
- 239000005885 Buprofezin Substances 0.000 description 7
- PRLVTUNWOQKEAI-VKAVYKQESA-N buprofezin Chemical compound O=C1N(C(C)C)\C(=N\C(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-VKAVYKQESA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 229920000642 polymer Polymers 0.000 description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 description 3
- 210000004408 hybridoma Anatomy 0.000 description 3
- 201000000050 myeloid neoplasm Diseases 0.000 description 3
- 125000000217 alkyl group Chemical group 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- PRLVTUNWOQKEAI-UHFFFAOYSA-N 2-(tert-butylimino)-5-phenyl-3-(propan-2-yl)-1,3,5-thiadiazinan-4-one Chemical compound O=C1N(C(C)C)C(=NC(C)(C)C)SCN1C1=CC=CC=C1 PRLVTUNWOQKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000001900 immune effect Effects 0.000 description 1
- 238000010324 immunological assay Methods 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- MYWUZJCMWCOHBA-VIFPVBQESA-N methamphetamine Chemical compound CN[C@@H](C)CC1=CC=CC=C1 MYWUZJCMWCOHBA-VIFPVBQESA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11211798A JP2001039959A (ja) | 1999-07-27 | 1999-07-27 | ブプロフェジンのハプテン化合物、抗体及び測定方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11211798A JP2001039959A (ja) | 1999-07-27 | 1999-07-27 | ブプロフェジンのハプテン化合物、抗体及び測定方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2001039959A JP2001039959A (ja) | 2001-02-13 |
| JP2001039959A5 true JP2001039959A5 (enExample) | 2006-09-14 |
Family
ID=16611793
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11211798A Withdrawn JP2001039959A (ja) | 1999-07-27 | 1999-07-27 | ブプロフェジンのハプテン化合物、抗体及び測定方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001039959A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115745990B (zh) * | 2022-11-08 | 2025-08-26 | 中国农业科学院农业质量标准与检测技术研究所 | 噻嗪酮半抗原、完全抗原和抗体的制备方法及应用 |
-
1999
- 1999-07-27 JP JP11211798A patent/JP2001039959A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Crago et al. | Distribution of IgA1-, IgA2-, and J chain-containing cells in human tissues | |
| AU560595B2 (en) | Human-human hybridomas for neoplasms | |
| US4816249A (en) | Monoclonal anti-idiotype antibodies | |
| EP0166623A2 (en) | Antibody lectin sandwich assay | |
| KR960702003A (ko) | 라파마이신 분석법(rapamycin assay) | |
| CA2265498A1 (en) | Staphylococcus aureus antigen | |
| EP0048357A1 (en) | Method for the determination of an antigen in solution | |
| EP0173648A2 (en) | New monoclonal antibodies to glycoconjugates, processes for their production, and applications | |
| US5171666A (en) | Monoclonal antibodies reactive with a cell-surface gylcoprotein expressed on human carcinomas | |
| US4692405A (en) | Monoclonal antibodies to antigen on activated human B-cells and assay therefor, protein antigenic determinant therefor and method of making same | |
| CA2036814A1 (en) | Monoclonal antibodies against tumor-associated antigens, a process for the preparation thereof and the use thereof | |
| JP2001039959A5 (enExample) | ||
| Carrel et al. | Reactivity spectrum of 30 monoclonal antimelanoma antibodies to a panel of 28 melanoma and control cell lines | |
| JP2555028B2 (ja) | ヒト非−小細胞肺癌に関するモノクロ−ナル抗体 | |
| CA2150497C (en) | Inhibitor and anti-inhibitor monoclonal antibodies specific for horseradish peroxidase | |
| JP4054681B2 (ja) | ヘリコバクター・ピロリを認識する抗体、およびヘリコバクター・ピロリを検出する方法 | |
| Toshio et al. | Preparation of specific antisera to estradiol 17-glucuronide | |
| WO1986004782A1 (en) | Monoclonal antibodies and method of immunizing therewith | |
| JP2000281645A5 (enExample) | ||
| JP4070372B2 (ja) | 抗ウラシルモノクローナル抗体 | |
| JP2001039953A5 (enExample) | ||
| US4649106A (en) | Distinguishing subsets of human cells | |
| JP2000095769A5 (enExample) | ||
| JPH11255786A5 (enExample) | ||
| Decken et al. | Monoclonal antibody due ABC 3 directed against transitional cell carcinoma. I. Production, specificity analysis, and preliminary characterization of the antigen |